T1	PROC 46 85	Ensayo clínico sobre la inmunogenicidad
T2	DISO 146 167	infectados por el VIH
#1	AnnotatorNotes T2	C0458074; Human immunodeficiency virus (HIV) status; Finding
T3	PROC 240 328	Ensayo clínico fase IV, abierto, de brazo único y multicéntrico sobre la inmunogenicidad
T4	PROC 561 583	consentimiento escrito
#2	AnnotatorNotes T4	C0811746; Obtain written consent; Health Care Activity
T5	CHEM 335 389	vacuna nonavalente frente al virus del papiloma humano
T6	DISO 401 422	infectados por el VIH
#3	AnnotatorNotes T6	C0458074; Human immunodeficiency virus (HIV) status; Finding
T7	DISO 496 500	SIDA
#4	AnnotatorNotes T7	C0001175; Acquired Immunodeficiency Syndrome; Disease or Syndrome
T8	PROC 715 724	protocolo
#5	AnnotatorNotes T8	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T9	DISO 772 802	infección crónica con el VIH-1
T10	PROC 843 846	CD4
#6	AnnotatorNotes T10	C0243009; CD4+ Lymphocyte Count; Laboratory Procedure
T11	ANAT 852 859	células
#7	AnnotatorNotes T11	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T12	ANAT 974 980	anales
#8	AnnotatorNotes T12	C0003461; Anus; Body Part, Organ, or Organ Component | C1278927; Entire anus; Body Part, Organ, or Organ Component
T13	PROC 806 826	Carga vírica del VIH
#9	AnnotatorNotes T13	C1168369; HIV viral load; Laboratory Procedure
T14	DISO 1070 1081	cáncer anal
#10	AnnotatorNotes T14	C0279637; Anal carcinoma; Neoplastic Process
T15	CHEM 92 134	vacuna frente al virus del papiloma humano
#11	AnnotatorNotes T15	C1512511; Human Papilloma Virus Vaccine; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T16	ANAT 1077 1081	anal
#12	AnnotatorNotes T16	C0003461; Anus; Body Part, Organ, or Organ Component | C1278927; Entire anus; Body Part, Organ, or Organ Component
T17	CHEM 1122 1141	vacuna frente a VPH
T18	Date 13 17	2018
T19	LIVB 109 134	virus del papiloma humano
#13	AnnotatorNotes T19	C0021344; human papillomavirus; Virus
T20	LIVB 138 145	hombres
#14	AnnotatorNotes T20	C0025266; Male population group; Population Group
T21	LIVB 164 167	VIH
#15	AnnotatorNotes T21	C0019682; HIV; Virus
T22	LIVB 188 195	hombres
#16	AnnotatorNotes T22	C0025266; Male population group; Population Group
T23	LIVB 364 389	virus del papiloma humano
#17	AnnotatorNotes T23	C0021344; human papillomavirus; Virus
T24	LIVB 393 400	hombres
#18	AnnotatorNotes T24	C0025266; Male population group; Population Group
T25	LIVB 419 422	VIH
#19	AnnotatorNotes T25	C0019682; HIV; Virus
T26	LIVB 443 450	hombres
#20	AnnotatorNotes T26	C0025266; Male population group; Population Group
T27	LIVB 529 538	Pacientes
#21	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	Age 732 755	≥18 años y < de 36 años
T30	LIVB 759 767	Paciente
#22	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Duration 782 789	crónica
#23	AnnotatorNotes T31	C0205191; chronic; Temporal Concept
T32	LIVB 812 818	vírica
#24	AnnotatorNotes T32	C0042776; Virus; Virus
T33	LIVB 823 826	VIH
#25	AnnotatorNotes T33	C0019682; HIV; Virus
T34	Duration 871 902	al menos los seis últimos meses
T35	LIVB 906 935	Hombres o mujeres transgénero
#26	AnnotatorNotes T35	C3266856; Transgendered Persons; Population Group
T37	PHYS 954 973	relaciones sexuales
#27	AnnotatorNotes T37	C0009253; Coitus; Organism Function
T38	LIVB 1015 1022	hombres
#28	AnnotatorNotes T38	C0025266; Male population group; Population Group
T39	LIVB 1138 1141	VPH
#29	AnnotatorNotes T39	C0021344; human papillomavirus; Virus
T29	PHYS 179 183	sexo
#30	AnnotatorNotes T29	C1286033; Sexual intercourse observable; Physiologic Function
T36	PHYS 434 438	sexo
#31	AnnotatorNotes T36	C1286033; Sexual intercourse observable; Physiologic Function
T40	PHYS 617 625	Entender
#32	AnnotatorNotes T40	C0162340; Comprehension; Mental Process
T41	LIVB 797 802	VIH-1
#33	AnnotatorNotes T41	C0019704; HIV-1; Virus
T42	PROC 689 696	visitas
#34	AnnotatorNotes T42	C1512346; Patient Visit; Health Care Activity
A1	Status T14 History_of
A2	Status T17 History_of
#35	AnnotatorNotes T1	C4054739; Immunogenicity Study; Research Activity
#36	AnnotatorNotes T9	C2363741; HIV-1 infection; Disease or Syndrome + C0151317; Chronic Infection; Disease or Syndrome
#37	AnnotatorNotes T17	C1512511; Human Papilloma Virus Vaccine; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
R1	Location_of Arg1:T12 Arg2:T37	
R2	Experiences Arg1:T35 Arg2:T37	
R3	Experiences Arg1:T38 Arg2:T37	
T43	Result_or_Value 847 862	>200 células/uL
R4	Has_Result_or_Value Arg1:T10 Arg2:T43	
T44	Result_or_Value 827 840	<50 copias/ml
R5	Has_Result_or_Value Arg1:T13 Arg2:T44	
R6	Overlap Arg1:T10 Arg2:T34	
R7	Overlap Arg1:T13 Arg2:T34	
R8	Causes Arg1:T41 Arg2:T9	
R9	Has_Duration_or_Interval Arg1:T9 Arg2:T31	
R10	Experiences Arg1:T30 Arg2:T9	
R11	Experiences Arg1:T20 Arg2:T15	
R12	Experiences Arg1:T20 Arg2:T2	
R13	Causes Arg1:T21 Arg2:T2	
R14	Experiences Arg1:T20 Arg2:T29	
R15	Experiences Arg1:T22 Arg2:T29	
R16	Experiences Arg1:T24 Arg2:T5	
R17	Causes Arg1:T25 Arg2:T6	
R18	Experiences Arg1:T24 Arg2:T6	
R19	Experiences Arg1:T24 Arg2:T36	
R20	Experiences Arg1:T26 Arg2:T36	
T45	Observation 539 546	capaces
#38	AnnotatorNotes T45	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R21	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T45	
T46	Observation 589 613	participar en el estudio
#39	AnnotatorNotes T46	C1278516; Patient participation status; Finding
R22	Before Arg1:T4 Arg2:T46	
R24	Overlap Arg1:T45 Arg2:T4	
T47	Observation 617 650	Entender el propósito del estudio
T48	Observation 659 696	disponibles para realizar las visitas
R25	Location_of Arg1:T16 Arg2:T14	
#40	AnnotatorNotes T5	C3863310; human papilloma virus vaccine, nonavalent; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
A3	Experiencer T20 Patient
A4	Experiencer T22 Patient
A5	Experiencer T24 Patient
A6	Experiencer T26 Patient
A7	Experiencer T27 Patient
A8	Experiencer T30 Patient
A9	Experiencer T35 Patient
A10	Experiencer T38 Patient
